# Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rituximab-is-effective-in-the-treatment-of-refractory-churg-strauss-syndrome-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ruth J. Pepper,Margarete A. Fabre,Carlos Pavésio,G. Gaskin,Rachel Jones,David Jayne,Charles D. Pusey,Alan D. Salama |
| Citations | 149 |
| DOI | 10.1093/rheumatology/ken175 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/rheumatology/article-pdf/47/7/1104/5066898/ken175.pdf |
| OpenAlex ID | https://openalex.org/W2140515181 |
| PMID | 18492710 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Ruth J. Pepper](https://scholariq.org/researchers/ruth-j-pepper/)
- [Carlos Pavésio](https://scholariq.org/researchers/carlos-pavesio/)

## Paper journal

- [Lara D. Veeken](https://scholariq.org/journals/lara-d-veeken/)

## Paper primary topic

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Paper topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.